Harold Bernstein

Harold Bernstein is a declared insider of Maze Therapeutics, Inc., with filings sourced from SEC (Form 4). In total, 28 filings cover trades dated from 29 December 2025 to 1 October 2026.

The open-market record consists of 15 sales worth €2.3M, with no purchase. The amount is not disclosed for 2 filings. The rest of the record consists of 13 option exercises. Since January 2026: no purchases and 15 sales on the market.

On 2 October 2026 came the latest disclosure, an open-market sale for €383k in Maze Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.